Terms: = Prostate cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4
41 results:
1. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract] [Full Text] [Related]
2. Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape.
Gui C; Wei J; Mo C; Liang Y; Cen J; Chen Y; Wang D; Luo J
Int J Biol Sci; 2023; 19(12):3951-3969. PubMed ID: 37564213
[No Abstract] [Full Text] [Related]
3. Association between Expression of Connective Tissue Genes and prostate cancer Growth and Progression.
Treacy PJ; Martini A; Falagario UG; Ratnani P; Wajswol E; Beksac AT; Wiklund P; Nair S; Kyprianou N; Durand M; Tewari AK
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108678
[TBL] [Abstract] [Full Text] [Related]
4. Identification of hub pathways and drug candidates in gastric cancer through systems biology.
Salarikia SR; Kashkooli M; Taghipour MJ; Malekpour M; Negahdaripour M
Sci Rep; 2022 Jun; 12(1):9099. PubMed ID: 35650297
[TBL] [Abstract] [Full Text] [Related]
5. Discovering biomarkers for hormone-dependent tumors: in silico study on signaling pathways implicated in cell cycle and cytoskeleton regulation.
Waszczykowska K; Prażanowska K; Kałuzińska Ż; Kołat D; Płuciennik E
Mol Genet Genomics; 2022 Jul; 297(4):947-963. PubMed ID: 35532795
[TBL] [Abstract] [Full Text] [Related]
6. Bisphenol S promotes the progression of prostate cancer by regulating the expression of col1a1 and COL1A2.
Liu S; He B; Li H
Toxicology; 2022 Apr; 472():153178. PubMed ID: 35405288
[TBL] [Abstract] [Full Text] [Related]
7. Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products.
Pagel CN; Kularathna PK; Sanaei R; Young ND; Hooper JD; Mackie EJ
Prostate; 2022 May; 82(6):723-739. PubMed ID: 35167724
[TBL] [Abstract] [Full Text] [Related]
8. Impact of radiation therapy on artificial urinary sphincter implantation in male patients: A multicenter study.
Mamane J; Sanchez S; Lellouch AG; Gaillard V; Poussot B; Tricard T; Saussine C; Brierre T; Game X; Beraud F; Biardeau X; Bruyere F; Robin D; El-Akri M; Chevallier D; Durand M; Bentellis I; Cousin T; Capon G; Cornu JN; Dupuis H; Monsaint H; Corbel L; Hermieu N; Hermieu JF; Pitout A; Lecoanet P; Peyronnet B; Leon P
Neurourol Urodyn; 2022 Jan; 41(1):332-339. PubMed ID: 34816473
[TBL] [Abstract] [Full Text] [Related]
9. Identification of immune cell infiltration pattern and related critical genes in metastatic castration-resistant prostate cancer by bioinformatics analysis.
Fan C; Lu W; Li K; Zhao C; Wang F; Ding G; Wang J
Cancer Biomark; 2021; 32(3):363-377. PubMed ID: 34151837
[TBL] [Abstract] [Full Text] [Related]
10. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring col1a1-targeting miRNA-92a-1-5p.
Yu L; Sui B; Fan W; Lei L; Zhou L; Yang L; Diao Y; Zhang Y; Li Z; Liu J; Hao X
J Extracell Vesicles; 2021 Jan; 10(3):e12056. PubMed ID: 33489015
[TBL] [Abstract] [Full Text] [Related]
11. Novel therapeutic compounds for prostate adenocarcinoma treatment: An analysis using bioinformatic approaches and the CMap database.
Li K; Fan J; Qin X; Wei Q
Medicine (Baltimore); 2020 Dec; 99(51):e23768. PubMed ID: 33371142
[TBL] [Abstract] [Full Text] [Related]
12. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract] [Full Text] [Related]
13. Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry.
Angel PM; Spruill L; Jefferson M; Bethard JR; Ball LE; Hughes-Halbert C; Drake RR
Prostate; 2020 Sep; 80(13):1071-1086. PubMed ID: 32687633
[TBL] [Abstract] [Full Text] [Related]
14. Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in prostate cancer Cells.
Hybel TE; Dietrichs D; Sahana J; Corydon TJ; Nassef MZ; Wehland M; Krüger M; Magnusson NE; Bauer J; Utpatel K; Infanger M; Grimm D; Kopp S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070055
[TBL] [Abstract] [Full Text] [Related]
15. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.
Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z
FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of CA1 mRNA and the CA I Protein in Tumor Cells Does Not Change the Gene Expression of the ECM Proteins.
Lakota J; Dubrovčáková M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963697
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of the economic burden of kidney stone disease in the UK: a retrospective cohort study with a mean follow-up of 19 years.
Geraghty RM; Cook P; Walker V; Somani BK
BJU Int; 2020 Apr; 125(4):586-594. PubMed ID: 31916369
[TBL] [Abstract] [Full Text] [Related]
18. Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized prostate cancer-A Pilot Study.
Fennessy FM; Fedorov A; Vangel MG; Mulkern RV; Tretiakova M; Lis RT; Tempany C; Taplin ME
Acad Radiol; 2020 Oct; 27(10):1432-1439. PubMed ID: 31862185
[TBL] [Abstract] [Full Text] [Related]
19. Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma.
Gerke JS; Orth MF; Tolkach Y; Romero-Pérez L; Wehweck FS; Stein S; Musa J; Knott MML; Hölting TLB; Li J; Sannino G; Marchetto A; Ohmura S; Cidre-Aranaz F; Müller-Nurasyid M; Strauch K; Stief C; Kristiansen G; Kirchner T; Buchner A; Grünewald TGP
Int J Cancer; 2020 Apr; 146(7):2036-2046. PubMed ID: 31732966
[TBL] [Abstract] [Full Text] [Related]
20. Proteomic Profiling of Human prostate cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.
Nguyen EV; Pereira BA; Lawrence MG; Ma X; Rebello RJ; Chan H; Niranjan B; Wu Y; Ellem S; Guan X; Wu J; Skhinas JN; Cox TR; Risbridger GP; Taylor RA; Lister NL; Daly RJ
Mol Cell Proteomics; 2019 Jul; 18(7):1410-1427. PubMed ID: 31061140
[TBL] [Abstract] [Full Text] [Related]
[Next]
